متابعة
Chrisandra Shufelt MD, MS
Chrisandra Shufelt MD, MS
Professor, Mayo Clinic
بريد إلكتروني تم التحقق منه على mayo.edu - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Contraceptive hormone use and cardiovascular disease
CL Shufelt, CN Bairey Merz
Journal of the American College of Cardiology 53 (3), 221-231, 2009
4012009
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction: a National Heart, Lung, and Blood Institute-sponsored …
LEJ Thomson, J Wei, M Agarwal, A Haft-Baradaran, C Shufelt, PK Mehta, ...
Circulation: Cardiovascular Imaging 8 (4), e002481, 2015
2622015
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study
J Wei, PK Mehta, BD Johnson, B Samuels, S Kar, RD Anderson, ...
JACC: Cardiovascular Interventions 5 (6), 646-653, 2012
2382012
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease
PK Mehta, P Goykhman, LEJ Thomson, C Shufelt, J Wei, YC Yang, E Gill, ...
JACC: Cardiovascular Imaging 4 (5), 514-522, 2011
2312011
Pregnancy and reproductive risk factors for cardiovascular disease in women
AC O’Kelly, ED Michos, CL Shufelt, JV Vermunt, MB Minissian, ...
Circulation research 130 (4), 652-672, 2022
2212022
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
CN Bairey Merz, EM Handberg, CL Shufelt, PK Mehta, MB Minissian, ...
European heart journal 37 (19), 1504-1513, 2016
2162016
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus
ML Ishimori, R Martin, DS Berman, P Goykhman, LJ Shaw, C Shufelt, ...
JACC: Cardiovascular Imaging 4 (1), 27-33, 2011
2032011
Hypothalamic amenorrhea and the long-term health consequences
CL Shufelt, T Torbati, E Dutra
Seminars in reproductive medicine 35 (03), 256-262, 2017
2002017
The 2022 hormone therapy position statement of the North American Menopause Society
SS Faubion, CJ Crandall, L Davis, SR El Khoudary, HN Hodis, RA Lobo, ...
Menopause 29 (7), 767-794, 2022
1992022
Sex-specific physiology and cardiovascular disease
CL Shufelt, C Pacheco, MS Tweet, VM Miller
Sex-Specific Analysis of Cardiovascular Function, 433-454, 2018
1972018
Sex hormones and the QT interval: a review
T Sedlak, C Shufelt, C Iribarren, CNB Merz
Journal of women's health 21 (9), 933-941, 2012
1702012
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI …
C Shufelt, P Bretsky, CM Almeida, BD Johnson, LJ Shaw, R Azziz, ...
The Journal of Clinical Endocrinology & Metabolism 95 (11), 4985-4992, 2010
1552010
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study
CL Shufelt, CNB Merz, RL Prentice, MB Pettinger, JE Rossouw, VR Aroda, ...
Menopause 21 (3), 260-266, 2014
1392014
Maternal recall of hypertensive disorders in pregnancy: a systematic review
JJ Stuart, CN Bairey Merz, SL Berga, VM Miller, P Ouyang, CL Shufelt, ...
Journal of women's health 22 (1), 37-47, 2013
1202013
Persistent chest pain and no obstructive coronary artery disease
A Phan, C Shufelt, CNB Merz
Jama 301 (14), 1468-1474, 2009
1112009
Diastolic dysfunction: improved understanding using emerging imaging techniques
D Daneshvar, J Wei, K Tolstrup, LEJ Thomson, C Shufelt, CNB Merz
American heart journal 160 (3), 394-404, 2010
1072010
Age at menarche and risk of cardiovascular disease outcomes: findings from the National Heart Lung and Blood Institute‐sponsored Women's Ischemia Syndrome Evaluation
JJ Lee, G Cook‐Wiens, BD Johnson, GD Braunstein, SL Berga, ...
Journal of the American Heart Association 8 (12), e012406, 2019
1032019
Preeclampsia and vascular function: a window to future cardiovascular disease risk
D Enkhmaa, D Wall, PK Mehta, JJ Stuart, JW Rich-Edwards, CNB Merz, ...
Journal of Women's Health 25 (3), 284-291, 2016
902016
Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery
CL Shufelt, JAE Manson
The Journal of Clinical Endocrinology & Metabolism 106 (5), 1245-1254, 2021
802021
Safety of testosterone use in women
CL Shufelt, GD Braunstein
Maturitas 63 (1), 63-66, 2009
802009
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20